Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) stock suffered a major decline of -10.4% on 3/10/25. The shares closed at $15.21. NORMAL trading volume accompanied the decline. Relative to the market the stock has been weak over the last nine months and has declined -19.6% during the last week.
Current PriceTarget Research Rating
Arrowhead Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Arrowhead Pharmaceuticals has a very low Power Rating of 12 and a very low Appreciation Score of 2, producing the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment